Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL4248351 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL1996289 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL1532531 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL1159815 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL6346934 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL1077296 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL8554033 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL414372 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL21490912 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 | |
| Toluene SCHEMBL856707 | 1.00 | ALDH1A1 (0.61) | ALDH1A1LMNAHSD17B10TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306546-A1 | GLYCAN, AND METHOD FOR PRODUCING MEDICINE CONTAINING GLYCAN | Daiichi Sankyo Company, Limited (JP) | 2024-01-17 | — | — | EP | disclosed |
| CN-116917341-A | Sugar chain and method for producing pharmaceutical product containing sugar chain | 第一三共株式会社 | 2023-10-20 | — | — | CN | disclosed |
| US-20220218713-A1 | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES | HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
| CN-111662314-B | Polycyclic aromatic compound or condensation polymer thereof, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2021-10-26 | — | — | CN | disclosed |
| CN-106987256-B | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same | JNC株式会社 | 2021-09-21 | — | — | CN | disclosed |
| US-20210113571-A1 | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES | HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD. (CN) | 2021-04-22 | — | — | US | disclosed |
| CN-106905367-B | Electron transport material or electron injection material, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2020-11-17 | — | — | CN | disclosed |
| CN-111909189-A | Polycyclic aromatic compound, multimer thereof, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2020-11-10 | — | — | CN | disclosed |
| CN-111892615-A | Polycyclic aromatic compound, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2020-11-06 | — | — | CN | disclosed |
| CN-105431439-B | Polycyclic aromatic compound, method for producing same, material for organic device, and application thereof | 学校法人关西学院 | 2020-09-25 | — | — | CN | disclosed |
| US-5280032-A | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same | TOYAMA CHEMICAL CO., LTD. (JP) | 1994-01-18 | — | — | US | disclosed |
| EP-0546338-A1 | Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method | CANON KABUSHIKI KAISHA (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0546529-A1 | Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same | TOYAMA CHEMICAL CO., LTD. (JP) | 1993-06-16 | — | — | EP | disclosed |
| CN-1068814-A | Tetracyclic antibiotic and manufacture method thereof | HOECHST AG (DE) | 1993-02-10 | — | — | CN | disclosed |
| EP-0146090-B1 | SIALYLOLIGOSACCHARIDES AND METHOD FOR PRODUCING THE SAME | RIKAGAKU KENKYUSHO (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-5091109-A | Ferroelectric; improved responsiveness | CANON KABUSHIKI KAISHA (JP) | 1992-02-25 | — | — | US | disclosed |
| EP-0415256-A2 | Mesomorphic compound, liquid crystal composition containing same and liquid crystal device using same | CANON KABUSHIKI KAISHA (JP) | 1991-03-06 | — | — | EP | disclosed |
| EP-0383281-A1 | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same | TOYAMA CHEMICAL CO., LTD. (JP) | 1990-08-22 | — | — | EP | disclosed |
| EP-0146090-A2 | Sialyloligosaccharides and method for producing the same | RIKAGAKU KENKYUSHO (JP) | 1985-06-26 | — | — | EP | disclosed |
| US-4294832-A | HYPOTENSIVE AGENTS, ANGIOTENSIN INHIBITORS | TANABE SEIYAKU CO., LTD. (JP) | 1981-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220218713-A1 | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES | FABP2, PLEC, FABP6 | ALDH1A1 852/4885LMNA 4184/4885HSD17B10 2454/4885 |
| US-20210113571-A1 | PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES | FABP2, PLEC, FABP6 | ALDH1A1 852/4885LMNA 4184/4885HSD17B10 2454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.